Charles Laurent

553 total citations
22 papers, 394 citations indexed

About

Charles Laurent is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Charles Laurent has authored 22 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Charles Laurent's work include Pulmonary Hypertension Research and Treatments (11 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Organic and Inorganic Chemical Reactions (4 papers). Charles Laurent is often cited by papers focused on Pulmonary Hypertension Research and Treatments (11 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Organic and Inorganic Chemical Reactions (4 papers). Charles Laurent collaborates with scholars based in United States, Canada and France. Charles Laurent's co-authors include Thomas E. Smithgall, Jean‐Claude Lacaille, Frank J. Delfino, Haiyun Cheng, Mounia Azzi, France Morin, Dany Salvail, Lisa Topolnik, Wayne S. Sossin and Luc DesGroseillers and has published in prestigious journals such as Journal of Neuroscience, Molecular and Cellular Biology and Neuroscience.

In The Last Decade

Charles Laurent

18 papers receiving 327 citations

Peers

Countries citing papers authored by Charles Laurent

Since Specialization

Citations

This map shows the geographic impact of Charles Laurent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Laurent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Laurent more than expected).

Fields of papers citing papers by Charles Laurent

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Laurent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Laurent. The network helps show where Charles Laurent may publish in the future.

Co-authorship network of co-authors of Charles Laurent

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Laurent. A scholar is included among the top collaborators of Charles Laurent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Laurent. Charles Laurent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The thromboxane receptor antagonist NTP42 promotes beneficial adaptation and preserves cardiac function in experimental models of right heart overload 2022 ·Frontiers in Cardiovascular Medicine ·(unknown), (unknown), Rui Adão, (unknown), (unknown), Viviana Salvatore, Helen M. Reid, Glória Conceição, (unknown), Aida Llucià‐Valldeperas, Jean-Baptiste Michel, Carmen Brás‐Silva, Charles Laurent, Luke Howard, David Montani, Marc Humbert, Anton Vonk Noordegraaf, Frédéric Perros, Pedro Mendes‐Ferreira, B. Therese Kinsella	4
2	Neurologic manifestations of giant cell arteritis 2022 ·Journal of Neurology ·Antoine Soulages, Igor Sibon, Jean‐Michel Vallat, Emmanuel Ellie, Frédéric Bourdain, Fanny Duval, (unknown), Marie‐Laure Martin‐Négrier, Guilhem Solé, Charles Laurent, (unknown), Gwendal Le Masson, Stéphane Mathis	4
3	Prostanoid receptor subtypes involved in treprostinil-mediated vasodilation of rat pulmonary arteries and in treprostinil-mediated inhibition of collagen gene expression of human lung fibroblasts 2020 ·Prostaglandins & Other Lipid Mediators ·Michel R. Corboz, (unknown), Sandra Gagnon, Daniel LaSala, Charles Laurent, Dany Salvail, Kuan‐Ju Chen, David Cipolla, Walter R. Perkins, Richard W. Chapman	12
4	Determination of the Prostanoid Receptor Subtype Involved in Treprostinil-Induced Cough in Guinea Pigs 2020 ·Michel R. Corboz, Sandra Gagnon, (unknown), Charles Laurent, Dany Salvail, Donna M. Omiatek, David Cipolla, Walter R. Perkins, Richard W. Chapman	2
5	Comparison of Treprostinil Palmitil Inhalation Suspension (TPIS) or Oral Sildenafil (Sild) in a Sugen/Hypoxia Rat Model of PAH 2020 ·Michel R. Corboz, Sandra Gagnon, (unknown), Charles Laurent, Adam J. Plaunt, (unknown), (unknown), (unknown), Zhili Li, David Cipolla, Walter R. Perkins, Richard W. Chapman	1
6	Inhaled hexadecyl-treprostinil provides pulmonary vasodilator activity at significantly lower plasma concentrations than infused treprostinil 2018 ·Pulmonary Pharmacology & Therapeutics ·Richard W. Chapman, Zhili Li, Michel R. Corboz, (unknown), Adam J. Plaunt, Donna M. Omiatek, Franziska Leifer, Charles Laurent, (unknown), Dany Salvail, (unknown), Walter R. Perkins, Vladimir Malinin	18
7	Inhaled Treprostinil-Prodrug Lipid Nanoparticle Formulations Provide Long-Acting Pulmonary Vasodilation 2018 ·Drug Research ·Franziska Leifer, Donna M. Omiatek, Kuan‐Ju Chen, Adam J. Plaunt, Dany Salvail, Charles Laurent, Michel R. Corboz, Zhili Li, (unknown), Walter R. Perkins, Vladimir Malinin	29
8	Agenesis of Internal Carotid Artery and Ischemic Stroke, One Case Report: A Review of Literature 2018 ·OALib ·(unknown), Mikel Martínez, Paul Desbordes, (unknown), (unknown), Charles Laurent, (unknown)	1
9	Preclinical Pharmacology and Pharmacokinetics of Inhaled Hexadecyl-Treprostinil (C16TR), a Pulmonary Vasodilator Prodrug 2017 ·Journal of Pharmacology and Experimental Therapeutics ·Michel R. Corboz, Zhili Li, Vladimir Malinin, Adam J. Plaunt, Donna M. Omiatek, Franziska Leifer, Kuan‐Ju Chen, Charles Laurent, (unknown), (unknown), Dany Salvail, Jianguo Zhuang, Fadi Xu, Aidan K. Curran, Walter R. Perkins, Richard W. Chapman	28
10	RP5063, a novel, multimodal, serotonin receptor modulator, prevents monocrotaline-induced pulmonary arterial hypertension in rats 2017 ·European Journal of Pharmacology ·(unknown), Jon E. Hawkinson, Marc Cantillon, (unknown), (unknown), Charles Laurent, Annie Bouchard, (unknown), Dany Salvail	21
11	RP5063, a novel, multimodal, serotonin receptor modulator, prevents Sugen 5416-hypoxia–induced pulmonary arterial hypertension in rats 2017 ·European Journal of Pharmacology ·(unknown), Jon E. Hawkinson, Marc Cantillon, (unknown), (unknown), Charles Laurent, Annie Bouchard, (unknown), Dany Salvail	19
12	Inhalation of dry powder INS1009 (DP-INS1009) does not activate the cough reflex in guinea pigs: a comparison with nebulized treprostinil 2017 ·Michel R. Corboz, Richard W. Chapman, Adam J. Plaunt, (unknown), Vladimir Malinin, Walter R. Perkins, (unknown), Charles Laurent, (unknown), (unknown), Zhili Li	2
13	Prolonged activity of inhaled treprostinil prodrug nanoparticles in a rat model of pulmonary arterial hypertension 2014 ·European Respiratory Journal ·Franziska Leifer, Donna M. Omiatek, Vladimir Malinin, (unknown), Zhili Li, (unknown), (unknown), (unknown), Charles Laurent, (unknown)	4
14	Treprostinil pharmacokinetics in rats are extended using inhaled prodrug formulations 2014 ·European Respiratory Journal ·Vladimir Malinin, Zhili Li, (unknown), Franziska Leifer, Donna M. Omiatek, (unknown), (unknown), Charles Laurent, (unknown)	3
15	Incorporation into lipid nanoparticles extends the duration of activity of treprostinil in an acute hypoxia rat model of pulmonary arterial hypertension 2014 ·European Respiratory Journal ·Donna M. Omiatek, Franziska Leifer, Vladimir Malinin, (unknown), (unknown), Zhili Li, (unknown), (unknown), Charles Laurent, (unknown)	1
16	KChIP1 modulation of Kv4.3-mediated A-type K+ currents and repetitive firing in hippocampal interneurons 2010 ·Neuroscience ·(unknown), Isabel Laplante, Charles Laurent, Jean‐Claude Lacaille	18
17	Effective immune restoration after immunosuppressant discontinuation in a lupus patient presenting progressive multifocal leukoencephalopathy 2009 ·Journal of the Neurological Sciences ·Guillaume Lefèvre, V. Queyrel, Claude‐Alain Maurage, Charles Laurent, David Launay, Arnaud Lacour, (unknown), S. Morell‐Dubois, M. Lambert, Hélène Maillard, Patrick Vermersch, É. Hachulla, Pierre‐Yves Hatron	13
18	Staufen1 Regulation of Protein Synthesis-Dependent Long-Term Potentiation and Synaptic Function in Hippocampal Pyramidal Cells 2008 ·Molecular and Cellular Biology ·(unknown), (unknown), Lisa Topolnik, Charles Laurent, Wayne S. Sossin, Luc DesGroseillers, Jean‐Claude Lacaille	66
19	The c-Fes tyrosine kinase cooperates with the breakpoint cluster region protein (Bcr) to induce neurite extension in a Rac- and Cdc42-dependent manner 2004 ·Experimental Cell Research ·Charles Laurent, Thomas E. Smithgall	16
20	The c-Fes protein-tyrosine kinase accelerates NGF-induced differentiation of PC12 cells through a PI3K-dependent mechanism 2003 ·Cellular Signalling ·Annemarie Shibata, Charles Laurent, Thomas E. Smithgall	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact